R
Richard T. Liggins
Researcher at University of British Columbia
Publications - 37
Citations - 3644
Richard T. Liggins is an academic researcher from University of British Columbia. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 20, co-authored 29 publications receiving 3588 citations.
Papers
More filters
Patent
Medical implants and fibrosis-inducing agents
William L. Hunter,David M. Gravett,Philip M. Toleikis,Arpita Maiti,Pierre E. Signore,Richard T. Liggins +5 more
TL;DR: In this paper, a combination of a fibrosis-inducing agent and an implant is used to induce fibrosis that may otherwise not occur when the implant is placed within an animal or increase fibrosis between the implant and the host tissue.
Patent
Polymer compositions and methods for their use
William L. Hunter,Philip M. Toleikis,David M. Gravett,Arpita Maiti,Richard T. Liggins,Aniko Takacs-Cox,Rui Avelar,Troy A. E. Loss +7 more
TL;DR: Compositions comprising anti-fibrotic agent(s) and/or polymeric compositions can be used in various medical applications including the prevention of surgical adhesions and treatment of inflammatory arthritis, treatment of scars and keloids, and the treatment of vascular disease as mentioned in this paper.
Patent
Medical implants and anti-scarring agents
William L. Hunter,David M. Gravett,Philip M. Toleikis,Arpita Maiti,Pierre E. Signore,Richard T. Liggins +5 more
TL;DR: In this article, the anti-scarring agent may be a cell cycle inhibitor, and may be used in conjunction with a second pharmaceutical agent, e.g., an antibiotic, to inhibit scarring that may occur when the implant is placed within an animal.
Patent
Intravascular devices and fibrosis-inducing agents
William L. Hunter,David M. Gravett,Philip M. Toleikis,Arpita Maiti,Pierre E. Signore,Richard T. Liggins,Dechi Guan +6 more
TL;DR: In this article, compositions and methods for use in the treatment of aneurysms and unstable arterial (vulnerable) plaque are described and compared for use with fibrosing agents.
Journal ArticleDOI
Solid-State Characterization of Paclitaxel
TL;DR: The data demonstrate the existence of a dihydrate form of paclitaxel that is the stable form in equilibrium with water at 37 degrees C but which dehydrates at temperatures > 45 degrees C.